Caplin Point Laboratories Limited

Informe acción NSEI:CAPLIPOINT

Capitalización de mercado: ₹112.5b

Caplin Point Laboratories Dirección

Dirección controles de criterios 3/4

El CEO de Caplin Point Laboratories' es Sridhar Ganesan , nombrado en Mar 2015, tiene una permanencia de 9.08 años. compensación anual total es ₹8.70M, compuesta por 95.4% salario y 4.6% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.12% de las acciones de la empresa, por valor de ₹123.60M. La antigüedad media del equipo directivo y de la junta directiva es de 8.6 años y 5.8 años, respectivamente.

Información clave

Sridhar Ganesan

Chief Executive Officer (CEO)

₹8.7m

Compensación total

Porcentaje del salario del CEO95.4%
Permanencia del CEO9.3yrs
Participación del CEO0.1%
Permanencia media de la dirección8.3yrs
Promedio de permanencia en la Junta Directiva5.9yrs

Actualizaciones recientes de la dirección

Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise

Sep 15
Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise

We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise

Sep 23
We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise

Recent updates

Caplin Point Laboratories (NSE:CAPLIPOINT) Strong Profits May Be Masking Some Underlying Issues

May 24
Caplin Point Laboratories (NSE:CAPLIPOINT) Strong Profits May Be Masking Some Underlying Issues

Does Caplin Point Laboratories (NSE:CAPLIPOINT) Deserve A Spot On Your Watchlist?

May 04
Does Caplin Point Laboratories (NSE:CAPLIPOINT) Deserve A Spot On Your Watchlist?

Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Low P/E No Reason For Excitement

Mar 07
Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Low P/E No Reason For Excitement

With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case

Oct 24
With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case

Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise

Sep 15
Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise

Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹2.50

Aug 11
Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹2.50

We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise

Sep 23
We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise

Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Will Receive A Bigger Dividend Than Last Year

Sep 11
Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Will Receive A Bigger Dividend Than Last Year

Is Now The Time To Put Caplin Point Laboratories (NSE:CAPLIPOINT) On Your Watchlist?

Jul 22
Is Now The Time To Put Caplin Point Laboratories (NSE:CAPLIPOINT) On Your Watchlist?

Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹2.00

May 15
Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹2.00

A Look At The Intrinsic Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Jan 21
A Look At The Intrinsic Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?

Oct 20
Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?

Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹1.50

Sep 17
Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹1.50

Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹1.50

Sep 03
Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹1.50

Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Intrinsic Value Is Potentially 28% Above Its Share Price

Aug 27
Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Intrinsic Value Is Potentially 28% Above Its Share Price

Is Caplin Point Laboratories (NSE:CAPLIPOINT) A Risky Investment?

Jun 12
Is Caplin Point Laboratories (NSE:CAPLIPOINT) A Risky Investment?

Estimating The Fair Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Apr 29
Estimating The Fair Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Does Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Have A Place In Your Dividend Portfolio?

Mar 24
Does Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Have A Place In Your Dividend Portfolio?

We Think Caplin Point Laboratories (NSE:CAPLIPOINT) Can Stay On Top Of Its Debt

Mar 11
We Think Caplin Point Laboratories (NSE:CAPLIPOINT) Can Stay On Top Of Its Debt

Do Caplin Point Laboratories's (NSE:CAPLIPOINT) Earnings Warrant Your Attention?

Feb 26
Do Caplin Point Laboratories's (NSE:CAPLIPOINT) Earnings Warrant Your Attention?

What We Learned About Caplin Point Laboratories' (NSE:CAPLIPOINT) CEO Pay

Feb 14
What We Learned About Caplin Point Laboratories' (NSE:CAPLIPOINT) CEO Pay

Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Feb 02
Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Can You Imagine How Jubilant Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Feel About Its 105% Share Price Gain?

Jan 21
Can You Imagine How Jubilant Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Feel About Its 105% Share Price Gain?

Does This Valuation Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Imply Investors Are Overpaying?

Jan 09
Does This Valuation Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Imply Investors Are Overpaying?

Could The Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Ownership Structure Tell Us Something Useful?

Dec 28
Could The Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Ownership Structure Tell Us Something Useful?

Is It Worth Buying Caplin Point Laboratories Limited (NSE:CAPLIPOINT) For Its 0.5% Dividend Yield?

Dec 16
Is It Worth Buying Caplin Point Laboratories Limited (NSE:CAPLIPOINT) For Its 0.5% Dividend Yield?

We Think Caplin Point Laboratories (NSE:CAPLIPOINT) Can Stay On Top Of Its Debt

Dec 04
We Think Caplin Point Laboratories (NSE:CAPLIPOINT) Can Stay On Top Of Its Debt

Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?

Nov 21
Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?

Here's What We Learned About The CEO Pay At Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Nov 08
Here's What We Learned About The CEO Pay At Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Sridhar Ganesan en comparación con los beneficios de Caplin Point Laboratories?
FechaCompensación totalSalarioIngresos de la empresa
Mar 31 2024n/an/a

₹5b

Dec 31 2023n/an/a

₹4b

Sep 30 2023n/an/a

₹4b

Jun 30 2023n/an/a

₹4b

Mar 31 2023₹9m₹8m

₹4b

Dec 31 2022n/an/a

₹4b

Sep 30 2022n/an/a

₹3b

Jun 30 2022n/an/a

₹3b

Mar 31 2022₹6m₹5m

₹3b

Dec 31 2021n/an/a

₹3b

Sep 30 2021n/an/a

₹3b

Jun 30 2021n/an/a

₹3b

Mar 31 2021₹6m₹5m

₹2b

Dec 31 2020n/an/a

₹2b

Sep 30 2020n/an/a

₹2b

Jun 30 2020n/an/a

₹2b

Mar 31 2020₹6m₹6m

₹2b

Dec 31 2019n/an/a

₹2b

Sep 30 2019n/an/a

₹2b

Jun 30 2019n/an/a

₹2b

Mar 31 2019₹6m₹6m

₹2b

Dec 31 2018n/an/a

₹2b

Sep 30 2018n/an/a

₹2b

Jun 30 2018n/an/a

₹1b

Mar 31 2018₹6m₹6m

₹1b

Compensación vs. Mercado: La compensación total de Sridhar($USD104.43K) está por debajo de la media de empresas de tamaño similar en el mercado Indian ($USD434.05K).

Compensación vs. Ingresos: La compensación de Sridhar ha aumentado más de un 20% en el último año.


CEO

Sridhar Ganesan (69 yo)

9.3yrs

Permanencia

₹8,700,000

Compensación

Dr. Sridhar Ganesan has been the Managing Director of Caplin Point Laboratories Ltd since March 28, 2015. Dr. Ganesan has been Whole Time Director of Caplin Point Laboratories Ltd since August 25, 2014. He...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Sridhar Ganesan
MD & Whole Time Director9.3yrs₹8.70m0.12%
₹ 134.8m
D. Muralidharan
Chief Financial Officer8.3yrs₹9.70m0.020%
₹ 22.5m
Partheeban Siddarth
Chief Operating Officer12.8yrs₹1.90m11.84%
₹ 13.3b
G. Venkatram
General Counsel1.8yrs₹2.30msin datos
M. Narayanan
Deputy Chief Financial Officerno datasin datossin datos
Ashok Partheeban
Head of Marketing - Latam Businessno datasin datos11.91%
₹ 13.4b
Thiagaraja Manikandan
Chief Transformation & Digital Officerno datasin datossin datos

8.3yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de CAPLIPOINT es experimentado (8.6 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Sridhar Ganesan
MD & Whole Time Director10.3yrs₹8.70m0.12%
₹ 134.8m
Paarthipan Chellappan
Non-Executive Non-Independent Chairman34.2yrssin datos18.64%
₹ 21.0b
Damodaran Sathyanarayanan
Non-Executive Independent Director7.6yrs₹160.00ksin datos
Chanderkanta Gariyali
Non-Executive Independent Director4.3yrs₹100.00ksin datos
R. Nagendran
Non-Executive Independent Director1.8yrs₹40.00ksin datos
S. Deenadayalan
Independent Non-Executive Director1.8yrs₹60.00k0.000090%
₹ 101.3k

5.9yrs

Permanencia media

71.5yo

Promedio de edad

Junta con experiencia: La junta directiva de CAPLIPOINT se considera experimentada (5.8 años de antigüedad promedio).